Order results by:
| Issue | Title | |
| Vol 7, No 2 (2015) | The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation | Abstract similar documents |
| A. V. Fonyakin | ||
| "... a new page in oral anticoagulant therapy aimed at preventing thromboembolic events in AF. Dabigatran ..." | ||
| Vol 4, No 1 (2012) | New possibilities in the prevention of stroke in atrial fibrillation | Abstract similar documents |
| Vladimir Anatolyevich Parfenov, S V Verbitskaya | ||
| "... and warfarin. The trial has indicated that the use of dabigatran in a dose of 150 mg twice daily results ..." | ||
| Vol 7, No 4 (2015) | Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice | Abstract similar documents |
| A. V. Fonyakin | ||
| "... aspects of the efficiency and safety of using the first direct thrombin inhibitor dabigatran etexilate ..." | ||
| Vol 6, No 2 (2014) | Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke | Abstract similar documents |
| A.V. Fonyakin | ||
| "... , one of which is dabigatran. A wealth of world clinical experience with dabigatran has confirmed its ..." | ||
| Vol 6, No 3 (2014) | The risk factors and prevention of stroke in atrial fibrillation | Abstract similar documents |
| V. A. Parfenov, S. V. Verbitskaya | ||
| "... randomized trials that show that novel oral anticoagulants (dabigatran, rivaroxaban, apixaban) are as good ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies | Abstract similar documents |
| V.A. Parfenov, S.V. Verbitskaya | ||
| "... – dabigatran. Presented results ARISTOTLE study, where have defined preference apixaban vs warfarin ..." | ||
| Vol 8, No 4 (2016) | GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... anticoagulant therapy for the prevention of thromboembolic events in AF. Dabigatran etexilate is the first DOAC ..." | ||
| Vol 5, No 2 (2013) | Dabigatran experience in primary and secondary prevention of cardioembolic stroke | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova | ||
| "... The review of novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) in stroke prevention ..." | ||
| Vol 8, No 1 (2016) | Hemorrhagic stroke and oral anticoagulants: What is to be done? | Abstract similar documents |
| M. A. Domashenko | ||
| "... discusses medical treatment in patients with HS during therapy with vitamin K antagonists (warfarin ..." | ||
| Vol 12, No 1 (2020) | The first experience with thrombolytic therapy for cerebral infarction in the Russian Federation after the use of idarucizumab | Abstract similar documents |
| E. V. Pudov, N. N. Sukhacheva, I. S. Petelina | ||
| "... fibrillation (AF) who took dabigatran 110 mg twice a day developed recurrent ischemic stroke (IS) that caused ..." | ||
| Vol 4, No 3 (2012) | A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... in the prevention of thromboembolic events in AF. More than 60 years, only warfarin and other vitamin K antagonists ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Current approaches to antithrombotic therapy in patients with cardioembolic stroke | Abstract similar documents |
| Oleg Ivanovich Vinogradov, A N Kuznetsov, N V Rybalko | ||
| Vol 6, No 4 (2014) | Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation | Abstract similar documents |
| A. V. Fonyakin | ||
| "... anticoagulants (NOACs), such as dabigatran, rivaroxaban, and apixaban. World clinical experience with NOACs in AF ..." | ||
| Vol 10, No 3 (2018) | Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| Vol 12, No 3 (2020) | Oral anticoagulant therapy in patients after intracerebral hemorrhage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, L. I. Syromyatnikova | ||
| "... in patients taking warfarin and direct OACs. The optimal OAC start or restart time after IUD, including ..." | ||
| Vol 6, No 1 (2014) | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations | Abstract similar documents |
| A.V. Fonyakin, L.A. Geraskina | ||
| "... and evaluates the potential of rivaroxaban as an alternative to warfarin. Rivaroxaban is shown to be a promising ..." | ||
| Vol 2, No 2 (2010) | Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy | Abstract similar documents |
| L. P. Ponomareva, N. F. Timoshkina, L. N. Sarantseva, A. A. Bulanov | ||
| "... , which is based on the normalization of blood pressure and the use of antiplatelet agents or warfarin ..." | ||
| Vol 12, No 4 (2020) | Atrial fibrillation and cognitive impairment: cerebral microbleeds as a new risk factor and possibilities of anticoagulant therapy (Part 2) | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova | ||
| "... that the latter increases with the use of warfarin, the effects of direct OACs (DOAC) in this regard require ..." | ||
| Vol 13, No 6 (2021) | Cardioembolic stroke: classification of causes and prevention strategies | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... or vitamin K antagonists (warfarin). The main types of heart valve pathology are prosthetic valves ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... compared to warfarin (p<0.0001), including a 51% greater hemorrhagic stroke (HS) risk reduction (p<0 ..." | ||
| 1 - 21 of 21 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
